From Models to Machines: The Emergence of Agentic Scientific Intelligence
Scientific artificial intelligence has moved decisively beyond the era of static, text-bound large language models into a regime defined by agency, embodiment, and action. Early generative systems were valued primarily for their ability to summarize literature or assist with drafting manuscripts, operating as linguistic accelerants rather than epistemic actors. That boundary has now eroded as multimodal, agentic architectures integrate perception, reasoning, and execution into unified scientific workflows. These systems no longer merely interpret scientific knowledge but increasingly intervene in its generation by orchestrating software tools, databases, and physical laboratory infrastructure. The shift marks a structural change in how research is conducted, not simply an incremental improvement in productivity. Scientific inquiry is becoming a distributed dialogue between human intent and machine-directed execution.
At the core of this transformation is the concept of agentic AI, where multiple specialized models collaborate through structured task decomposition rather than monolithic reasoning. Each agent operates within a defined functional role, such as literature retrieval, hypothesis synthesis, experimental planning, or quality control. This division of cognitive labor allows scientific problems to be reframed as modular processes that can be optimized independently yet coordinated coherently. Unlike earlier automation, which rigidly encoded protocols, agentic systems adapt dynamically to intermediate results and contextual uncertainty. The result is a form of computational reflexivity that mirrors, and in some cases surpasses, traditional human research workflows. Scientific reasoning thus becomes an emergent property of interacting agents rather than a single inferential chain.
Crucially, these systems are now embedded within physical environments through laboratory automation and robotics. Autonomous platforms can execute experimental protocols, capture high-dimensional data, and iteratively refine conditions based on algorithmic feedback. This coupling of language-based reasoning with material action collapses the traditional separation between planning and experimentation. The laboratory itself becomes a computational substrate, responsive to AI-generated directives and optimized through continuous learning loops. What once required weeks of human coordination across instruments can now unfold as a tightly integrated, machine-mediated process. The laboratory is no longer a passive site of execution but an active participant in discovery.
Yet this transition introduces profound epistemic tensions that cannot be ignored. When machines propose hypotheses, select experiments, and interpret results, questions of authorship, responsibility, and scientific judgment inevitably arise. The authority to define what constitutes a valid experiment or a meaningful result becomes partially delegated to algorithmic systems. Consequently, scientific practice must renegotiate the boundaries between automation and insight, efficiency and understanding. Rather than concluding this phase, these tensions instead open the conceptual space for a deeper reorganization of science itself. It is within this unresolved terrain that the scAInce paradigm begins to take shape.
Automated Cognition: Literature, Hypotheses, and Experimental Design at Scale
The automation of scientific cognition begins with the literature, long regarded as the intellectual memory of research communities. Agentic AI systems now perform large-scale retrieval, screening, and synthesis of scholarly corpora with a depth and speed that fundamentally alters evidence aggregation. These systems parse heterogeneous publications, align concepts across terminological boundaries, and generate structured representations of prior knowledge. The task is no longer simple summarization but the construction of machine-navigable knowledge graphs that encode relationships, uncertainties, and gaps. In doing so, AI transforms literature from a static archive into an active, queryable substrate for reasoning. Scientific context becomes computationally explicit rather than implicitly human-held.
Building on this substrate, agentic models extend their reach into hypothesis generation, a domain traditionally framed as irreducibly human. By embedding diverse data modalities into shared representational spaces, AI systems can surface latent associations across molecular biology, clinical phenotypes, materials properties, or environmental signals. These associations do not claim causal authority but instead function as prompts for targeted inquiry. Hypotheses emerge as ranked candidates based on informational novelty, plausibility, and testability rather than narrative elegance. This reorientation shifts creativity from inspiration toward systematic exploration of combinatorial possibility spaces. Scientific imagination becomes augmented by algorithmic breadth.
Experimental design represents the next frontier in this automated cognitive pipeline. Agentic systems increasingly propose protocols by simulating experimental outcomes under varying constraints and objectives. These simulations incorporate prior data, mechanistic assumptions, and operational limitations to recommend designs that maximize information yield. The process mirrors classical statistical planning but operates continuously and adaptively rather than episodically. Experimental protocols thus become provisional artifacts, revised in real time as new data emerge. The rigidity of predefined methods gives way to fluid, data-responsive experimentation.
However, the expansion of automated cognition introduces new forms of fragility into scientific practice. Algorithmic bias in training data can skew hypothesis generation toward overrepresented domains while neglecting marginal or emerging fields. Automated design systems may optimize for measurable outcomes at the expense of exploratory depth or conceptual risk. Moreover, the opacity of large-scale models complicates the task of scientific validation and peer scrutiny. These challenges do not negate the value of automation but instead underscore the need for deliberate governance. As cognition becomes computationally mediated, the infrastructure supporting scientific judgment must evolve accordingly.
Self-Driving Laboratories and the Materialization of scAInce
The convergence of agentic AI with laboratory automation marks the material realization of computational science at scale. Self-driving laboratories integrate robotic platforms, sensor networks, and real-time analytics into closed experimental loops. Within these environments, AI agents design experiments, dispatch instructions to hardware, and interpret resulting data without continuous human intervention. The cycle repeats iteratively, allowing rapid traversal of experimental parameter spaces. What distinguishes these systems is not speed alone but their capacity for adaptive learning across physical and digital domains. Experimentation becomes a continuous optimization process rather than a sequence of discrete trials.
In the life sciences, these platforms enable high-throughput exploration of biological systems with unprecedented granularity. Automated imaging, multi-omics profiling, and microphysiological models generate rich datasets that feed directly into learning algorithms. AI systems extract phenotypic signatures, detect subtle perturbations, and adjust experimental conditions accordingly. The result is a form of experimental intelligence that treats biological complexity as navigable rather than prohibitive. The laboratory shifts from hypothesis testing toward hypothesis co-evolution with data. Discovery becomes iterative in both design and interpretation.
Materials science and chemistry exhibit parallel transformations as autonomous synthesis platforms explore vast compositional spaces. AI-guided systems propose candidate structures, execute synthesis routes, and assess properties with minimal human mediation. Failed experiments are not endpoints but informative signals that refine subsequent iterations. This reframing of failure as data accelerates convergence toward viable solutions. The material world becomes increasingly legible to computational exploration. Physical constraints remain, but they are now incorporated into adaptive search strategies rather than addressed retrospectively.
Nevertheless, the autonomy of such laboratories raises critical concerns about reproducibility, safety, and accountability. When experimental decisions are distributed across interacting agents and machines, tracing causal responsibility becomes nontrivial. Regulatory frameworks designed for static instruments struggle to accommodate adaptive, learning systems. Moreover, access to these platforms risks becoming concentrated among well-resourced institutions, exacerbating global disparities in research capacity. These unresolved issues do not halt progress but instead frame the ethical and structural stakes of scAInce. As laboratories gain agency, governance must become as dynamic as the systems it seeks to regulate.
Science for AI: Reorganizing Knowledge in the scAInce Paradigm
scAInce represents a conceptual inversion in the relationship between science and artificial intelligence. Rather than viewing AI solely as a tool applied to existing scientific practices, scAInce treats the scientific enterprise itself as an optimizable system for machine reasoning. Knowledge production is reorganized to maximize machine interpretability, scalability, and reuse. Publications, datasets, and experimental protocols are increasingly structured for algorithmic consumption rather than narrative exposition. The unit of scientific value shifts from isolated findings to interoperable, machine-readable contributions. Science becomes a substrate for continuous computational refinement.
This reorganization places metadata at the center of epistemic value. Experimental details, provenance information, and contextual annotations are no longer ancillary but foundational. Machine-readable standards enable AI systems to compare, integrate, and critique findings across domains and time. The result is a cumulative knowledge architecture that supports automated reasoning at scale. Without such structure, even vast datasets remain opaque to algorithmic insight. Metadata thus becomes the connective tissue of scAInce.
The paradigm also encourages the creation of large, quality-controlled megasets that supersede fragmented studies. Coordinated data generation efforts reduce redundancy and amplify collective informational value. AI systems, in turn, identify gaps within these megasets and prioritize experiments that promise maximal uncertainty reduction. Funding and research agendas may increasingly be informed by such information-theoretic assessments. This feedback loop aligns resource allocation with epistemic efficiency rather than disciplinary tradition. Science becomes increasingly self-directing through computational evaluation.
Yet scAInce carries inherent risks that demand careful stewardship. Prioritizing machine-tractable problems may marginalize qualitative, exploratory, or data-poor disciplines. Algorithmic optimization could inadvertently narrow the diversity of scientific inquiry. Ensuring equitable access to computational infrastructure remains a pressing challenge. These tensions do not undermine scAInce but instead define its ethical frontier. The future of scientific discovery will depend not only on what AI enables but on how deliberately humanity chooses to shape its integration.
Study DOI: https://doi.org/10.3389/frai.2025.1649155
Engr. Dex Marco Tiu Guibelondo, B.Sc. Pharm, R.Ph., B.Sc. CompE
Editor-in-Chief, PharmaFEATURES


Devin Swanson’s leadership at Johnson & Johnson Innovative Medicines redefines external innovation as a tightly governed, AI-enabled translational system integrating multi-modal drug discovery, biomarker strategy, and capital-efficient execution.

A systems-level analysis of how Shicheng Guo is architecting AI-driven, human data–centric drug development at Arrowhead Pharmaceuticals.

Clinical data warehouse governance determines how integrated health data can be responsibly accessed, shared, and reused to enable modern biomedical research.
Igor Nasonkin’s systems-driven approach at Phythera Therapeutics reframes oncology drug development from single-target inhibition to AI-enabled polypharmacologic network modulation using nature-derived molecular architectures.
A systems-level examination of how Mehran F. Moghaddam operationalizes DMPK, externalized R&D, and lipid-mediated therapeutics into a predictive, high-velocity biotech development architecture.
David Weitz of Syrna Therapeutics explores how small molecule modulation of mRNA, enabled by AI-driven discovery and platform-centric execution, is redefining the boundaries of druggable biology.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings